Effect of Light Exercise on Renal Hemodynamics in Patients with Hypertension and Chronic Renal Disease

REFERENCES

• Smith HW. The control of the renal circulation. Exercise. In: Smith HW, ed. The kidney. Structure, and function in health and disease. New York: Oxford University Press, 1951: 438–41.
   Google Scholar
• Chapman CB, Henschel A, Minckler J, Forsgren A, Keys A. The effect of exercise on renal plasma flow in normal male subjects. J Clin Invest 1948; 27: 639–44.
   Google Scholar
• Poortmans JR. Exercise and renal function. Sports Med 1984; 1: 125–53.
   PubMed Web of Science ®Google Scholar
• Svarstad E, Iversen BM, Ofstad J. Extended measure-ments of glomerular filtration rate and effective renal plasma flow in ambulatory patients. Scand J Urol Nephrol 1995; 29: 375–82.
   Google Scholar
• Tidgren B, Hjemdahl P, Theodorsson E, Nussberger J. Renal neurohormonal and vascular responses to dynamic exercise in humans. J Appl Physiol 1991; 70: 2279–86.
   PubMed Web of Science ®Google Scholar
• Kotchen TA, Hartley LH, Rice TW, Mougey EH, Jones IG, Mason JW. Renin, norepinephrine and epinephrine responses to graded exercise. J Appl Physiol 1971; 31: 178–84.
   PubMed Web of Science ®Google Scholar
• Perrault H, Cantin M, Thibault G, Brisson GR, Brisson G, Beland M. Plasma atrial natriuretic peptide during brief upright and supine exercise in humans. J Appl Physiol 1989; 66: 2159–67.
   PubMed Web of Science ®Google Scholar
• Weidmann P, Schohn D, Laederach K, Uehlinger DE, Gnädinger MP, Shaw S. Catecholamines and their possible role in hypertension associated with impaired renal function. Contrib Nephrol 1987; 54: 159–76.
   Google Scholar
• Darwish R, Elias AN, Vaziri ND, Pahl M, Powers D, Stokes JD. Plasma and urinary catecholamines and their metabolites in chronic renal failure. Arch Intern Med 1984; 144: 69–71.
   PubMedGoogle Scholar
• Converse RL, Jacobsen TN, Toto RD, Jost CMT, Consentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912–8.
   Google Scholar
• Lowe RD, Scroop GC. Effects of angiotensin on the autonomic nervous system. Am Heart J 1970; 79: 562–7.
   PubMed Web of Science ®Google Scholar
• Fiorica V, Kem DC. Plasma norepinephrine, blood pressure and heart rate response to graded change in body position. Aviat Space Environ Med 1985; 56: 1166–71.
   PubMedGoogle Scholar
• Kohrt WM, Spina RJ, Ehsani AA, Cryer PE, Holloszy JO. Effects of age, adiposity, and fitness level on plasma catecholamine responses to standing and exercise. J Appl Physiol 1993; 75: 1828–35.
   Google Scholar
• Shenker Y, Port FK, Swartz RD, Gross MD, Grekin RJ. Atrial natriuretic hormone secretion in patients with renal failure. Life Sci 1987; 41: 1635–44.
   Google Scholar
• Suda S, Weidmann P, Saxenhofer H, Cottier C, Shaw SG, Ferrier C. Atrial natriuretic factor in mild to moderate chronic renal failure. Hypertension 1988; 11: 483–90.
   PubMed Web of Science ®Google Scholar
• Oie BK, Myking OL, Hoff PI, Ohm OJ. The acute effects of induced tachycardia on coronary sinus and arterial plasma levels of atrial natriuretic peptide and on arterial catecholamines. Scand J Clin Lab Invest 1994; 54: 155–9.
   PubMed Web of Science ®Google Scholar
• Uehlinger DE, Weidmann P, Gnalinger MP, Shaw S, Lang RE. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab 1986; 63: 669–74.
   Google Scholar
• Svarstad E, Myking O, Ofstad J, Iversen BM. Sympa-thetic nervous system overactivity in hypertensive patients with chronic renal failure: role of upright body position. Scand J Urol Nephrol 2001; 35: 393–400.
   PubMedGoogle Scholar
• Castenfors J. Renal function during exercise. Acta Physiol Scand 1967; 70 (Suppl 293): 1–44.
   PubMedGoogle Scholar
• Taverner D, Craig K, Mackay I, Watson ML. Effects of exercise on renal function in patients with moderate impairment of renal function compared to normal men. Nephron 1991; 57: 288–92.
   PubMed Web of Science ®Google Scholar
• Omvik P, Lund-Johansen P. Combined captopril and hydrochlorothiazide therapy in severe hypertension: long-term haemodynamic changes at rest and during exercise. J Hypertens 1984; 2: 73–80.
   PubMedGoogle Scholar
• Aldigier JC, Huang H, Dalmay F, Lartigue M, Baussant T, Chassain AP, et al. Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 1993; 21: 289–95.
   PubMed Web of Science ®Google Scholar
• Katzman PL, Hulthen UL, Wildeldt B. The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catechola-mines and aldosterone in patients with essential hyper-tension. Br J Clin Pharmacol 1986; 21: 633–40.
   Google Scholar
• Terland O, Grønberg M, Flatmark T. The effect of calcium channel blockers on the H+-ATPase and bioenergetics of bovine adrenal catecholamine storage vesicles. Eur J Pharmacol 1991; 207: 37–41.
   PubMed Web of Science ®Google Scholar
• Zsotér T'T, Wolchinsky C. Effects of calcium antagonists on sympathetic nerve activity. Can J Cardiol 1986; 2: 256–60.
   PubMedGoogle Scholar
• Van Bortel LN, Schiffers PM, Bohm RO, Mooij JM, Rahn KH, Struyker-Boudier HA. The influence of chronic treatment with verapamil on plasma natriuretic peptide levels in young and elderly hypertensive patients. Eur J Clin Pharmacol 1990; 39 (Suppl 1): S39–40.
   Google Scholar
• Antonicelli R, Tomassini PF, Galletti P, Gambini C, Marini M, Amadio L, et al. Age-related antihypertensive and haemodynamic effects of verapamil SR: clinical results and effects on atrial natriuretic peptide. Eur J Clin Pharmacol 1990; 39 (Suppl 1): S29–33.
   PubMedGoogle Scholar
• Fioretto P, Frigato F, Velussi M, Riva F, Muollo B, Carraro A, et al. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am J Hypertens 1992; 5: 837–46.
   PubMed Web of Science ®Google Scholar
• Doubell AF, Thibault G. Calcium is involved in both positive and negative modulation of the secretory system for ANP. Am J Physiol 1994; 266: H1854–63.
   PubMedGoogle Scholar
• Kvam Fl, Ofstad J, Iversen BM. Effects of antihyperten-sive drugs on autoregulation of renal blood flow and glomerular capillary pressure in SHR. Submitted.
   Google Scholar
• Carmines PK, Navar G. Disparate effect of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol 1989; 256: F1015–20.
   PubMed Web of Science ®Google Scholar
• Loutzenhiser R, Epstein M. Effects of calcium channel antagonists on renal hemodynamics. Am J Physiol 1985; 249: F619–29.
   PubMed Web of Science ®Google Scholar
• Kiberd BA. Cyclosporine-induced renal dysfunction in human renal allograft recipients. Transplantation 1989; 48: 965–9.
   PubMed Web of Science ®Google Scholar
• Berg KJ, Holdaas H, Endresen L, Fauchald P, Hartmann A, Pran T, et al. Effects of isradipine on renal function in cyclosporine treated renal transplanted patients. Nephrol Dial Transplant 1991; 6: 725–30.
   PubMed Web of Science ®Google Scholar
• Sonnenberg H, Veress T. Cellular mechanism of release of atrial natriuretic factor. Biochem Biophys Res Commun 1984; 124: 443–9.
   PubMed Web of Science ®Google Scholar
• Camargo MJF, Kleinert HD, Atlas SA, Sealey JE, Laragh JH, Maack T. Ca-dependent hemodynamic and natri-uretic effects of atrial extract in isolated rat kidney. Am J Physiol 1984; 246: F447–6.
   PubMed Web of Science ®Google Scholar
• Weidmann P, Hasler L, Gnatlinger MP, Lang RE, Uehlinger DE, Shaw S, et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734–42.
   PubMed Web of Science ®Google Scholar
• Maid DD, Ma JZ, Louis TA, Kasiske BL. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995; 155: 1073–80.
   PubMedGoogle Scholar
• Kohno M, Yasunari K, Takaori K, Takeda T. Increased plasma ANP in patients with severe hypertension and its decline with antihypertensive therapy with nefedipine. Arch Intern Med 1986; 146: 1226–7.
   PubMedGoogle Scholar
• Chalmers JP, Wing LMH, West HJ, Bune AJ, Elliott JM, Morris MJ, et al. Effects of enalapril and hydrochloro-thiazide on blood pressure, renin angiotensin system and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study. Aust N Z J Med 1986; 16: 475–80.
   PubMedGoogle Scholar